XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended Jun... (shares Amount capital ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007

Date:8/19/2007

shares Amount capital

----------- ------- -------

BALANCE AT DECEMBER 31, 2006 220,124,349 1,072 136,611

CHANGES DURING THE SIX MONTHS

ENDED JUNE 30, 2007:

Comprehensive loss - loss for

the period -- -- --

Non-employee stock option

compensation expenses -- -- 5

Employee stock option compensation

expenses -- -- 964

Exercise of stock options 30,000 (**) 3

----------- ------- --------

BALANCE AT JUNE 30, 2007 220,154,349 1,072 137,583

=========== ======= ========

Deficit

accumulated

during the

development

stage Total

--------- ---------

BALANCE AT DECEMBER 31, 2006 (114,923) 22,760

CHANGES DURING THE SIX MONTHS

ENDED JUNE 30, 2007:

Comprehensive loss - loss for the

period (14,649) (14,649)

Non-employee stock option

compensation expenses -- 5

Employee stock option compensation

expenses -- 964

Exercise of stock options -- 3

--------- ---------

BALANCE AT JUNE 30, 2007 (129,572) 9,083

========= =========

(**) Represents an amount less than $1,000.

<

SOURCE XTL Biopharmaceuticals Ltd

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:

Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6 ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2 ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3 ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3 Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2 Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3

[0] AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology [0] ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis [0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia [0] Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures

Other Biology Technology:Fujitsu PalmSecure and HT Systems' PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft 2 Fujitsu PalmSecure and HT Systems' PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft 3 Fujitsu PalmSecure and HT Systems' PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft 4 Fujitsu PalmSecure and HT Systems' PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft 5 Spectral to bring anti-sepsis therapy to the U.S. market 2 Spectral to bring anti-sepsis therapy to the U.S. market 3 AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM) 2 AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM) 3

Fujitsu PalmSecure and HT Systems' PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft Spectral to bring anti-sepsis therapy to the U.S. market AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM)

Breaking Biology News(10 mins):Delivering medicine directly into a tumor 2 Genome BC collaborates with Chile and Norway to sequence salmon genome 2 Study shows nearly 1/3 of human genome is involved in gingivitis 2 Study shows nearly 1/3 of human genome is involved in gingivitis 3 ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results 51826 1 ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results 51826 2 ParagonRx Files with FDA REMS Panel Interim Analysis for Opioid Drugs Study 13051 1 CorVel Announces Earnings Release Webcast 51821 1 CorVel Announces Earnings Release Webcast 51821 2

[0] Delivering medicine directly into a tumor [0] Genome BC collaborates with Chile and Norway to sequence salmon genome [0] Study shows nearly 1/3 of human genome is involved in gingivitis

Other Biology News:Supercomputer provides massive computational boost to biomedical research at TGen 2 Supercomputer provides massive computational boost to biomedical research at TGen 3 Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok 2 Stanford researchers: Global warming is killing frogs and salamanders in Yellowstone Park 2 Stanford researchers: Global warming is killing frogs and salamanders in Yellowstone Park 3

Supercomputer provides massive computational boost to biomedical research at TGen Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok Stanford researchers: Global warming is killing frogs and salamanders in Yellowstone Park

Biology Products:

Rabbit Anti-cdc42 / Rac Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents Goat Anti-DDDDK tag Polyclonal Antibody, Fluorescein Conjugated from Abcam Rabbit Anti-TRPM8 Polyclonal Antibody, Unconjugated from Abcam ThermoTWISTER comfort from QUANTIFOIL Instruments